Muhammed Majeed;Kalyanam Nagabhushanam;Lakshmi Mundkur
发明人:
Muhammed Majeed,Kalyanam Nagabhushanam,Lakshmi Mundkur
申请号：
US16238677
公开号：
US20190209509A1
申请日:
2019.01.03
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention discloses a novel use of Calebin A in the prevention of hepatocellular damage. More specifically, the invention discloses the use of Calebin A in mitigating hepatocellular damage in drug and alcohol induced liver toxicity. The invention further discloses a method for the management of hyperglycemia, associated with drug and alcohol induced liver damage by increasing glucose uptake using Calebin A or a composition comprising Calebin A.
